# Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis

> **NCT06963203** · — · RECRUITING · sponsor: **Andrea Goldmann** · enrollment: 486 (estimated)

## Conditions studied

- Graves Disease
- Amiodarone-Induced Thyrotoxicosis
- Thyroidectomy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06963203
- **Lead sponsor:** Andrea Goldmann
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2027-06
- **Final completion:** 2027-12
- **Target enrollment:** 486 (ESTIMATED)
- **Last updated:** 2025-07-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06963203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06963203, "Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06963203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
